Jeff Michalski

14PUBLICATIONS
101CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyOther creative arts and writing not elsewhere classifiedCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 08, 2026
Participant Heterogeneity in the Prostate Cancer Biobank of the NRG: An Obstacle to Broadening the Reach of Precision Oncology.

|Sep 03, 2024
Bladder-Preserving Trimodality Treatment for High-Grade T1 Bladder Cancer: Results From Phase II Protocol NRG Oncology/RTOG 0926.

Douglas M Dahl, Joseph P Rodgers, William U Shipley

|May 17, 2024
Long-Term Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Noninferiority Study Comparing Two Fractionation Schedules in Patients With Low-Risk Prostate Cancer.

W Robert Lee, James J Dignam, Mahul B Amin

|May 15, 2024
Using the Cell-Cycle Risk Score to Predict the Benefit of Androgen-Deprivation Therapy Added to Radiation Therapy in Patients With Newly Diagnosed Prostate Cancer.

Jonathan D Tward, Lauren Lenz, Alexander Gutin

|Aug 28, 2023
Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate.

Soumyajit Roy, Tahmineh Romero, Jeff M Michalski

|Jun 14, 2023
Effect of Brachytherapy With External Beam Radiation Therapy Versus Brachytherapy Alone for Intermediate-Risk Prostate Cancer: NRG Oncology RTOG 0232 Randomized Clinical Trial.

Jeff M Michalski, Kathryn A Winter, Bradley R Prestidge

Pageof 3

Frequent Collaborators

7 joint publications

Howard M Sandler

5 joint publications

Deborah Watkins Bruner

4 joint publications

Jason Efstathiou

3 joint publications

Brian C Baumann